Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
JCO Precision Oncology
|
September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Blood
|
November 5, 2025
Multinational Assessment of Absolute Neutrophil Counts and White Blood Cell Counts Among Healthy Duffy Null Adults
Stephen P Hibbs, Israel Chipare, Amr J Halawani, et al.
Science Translational Medicine
|
September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas
Pierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Blood Advances
|
January 10, 2024
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia
Emma-Jayne Minihane, Leah Krotee, Jason Wu, et al.
Blood Advances
|
October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Leukemia & Lymphoma
|
March 12, 2025
Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults
Philip C Amrein, Frederic I Preffer, Geoffrey Fell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2019
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia
Mark Bustoros, Romanos Sklavenitis-Pistofidis, Prashant Kapoor, et al.
Blood Advances
|
December 5, 2025
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor risk MDS/AML
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Blood Cancer Discovery
|
December 5, 2022
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Elisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
JCO Precision Oncology
|
September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
Blood
|
November 5, 2025
Multinational Assessment of Absolute Neutrophil Counts and White Blood Cell Counts Among Healthy Duffy Null Adults
Stephen P Hibbs, Israel Chipare, Amr J Halawani, et al.
Science Translational Medicine
|
September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas
Pierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Blood Advances
|
January 10, 2024
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia
Emma-Jayne Minihane, Leah Krotee, Jason Wu, et al.
Blood Advances
|
October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Leukemia & Lymphoma
|
March 12, 2025
Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults
Philip C Amrein, Frederic I Preffer, Geoffrey Fell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2019
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia
Mark Bustoros, Romanos Sklavenitis-Pistofidis, Prashant Kapoor, et al.
Blood Advances
|
December 5, 2025
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor risk MDS/AML
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Blood Cancer Discovery
|
December 5, 2022
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Elisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
Page
of 5